Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study

被引：0
|
作者：
Hattori, N. [1 ]
Takeda, A. [2 ]
Takeda, S. [3 ]
Nishimura, A. [3 ]
Kitagawa, T. [3 ]
Mochizuki, H. [4 ]
Nagai, M. [5 ]
Takahashi, R. [6 ]
机构：
[1] Juntendo Univ, Dept Neurol, Fac Med, Tokyo, Japan
[2] Natl Hosp Org Sendai Nishitaga Hosp, Dept Neurol, Sendai, Miyagi, Japan
[3] Takeda Pharmaceut Co Ltd, Japan Dev Ctr, Osaka, Japan
[4] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan
[5] Ehime Univ Hosp, Clin Therapeut Trial Ctr, Toon, Ehime, Japan
[6] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2017年 / 381卷
关键词：
D O I：
10.1016/j.jns.2017.08.662
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
634
引用
收藏
页码：231 / 232
页数：2
相关论文
共 50 条
  • [31] Trial in Progress: Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Cold Agglutinin Disease (CASCADE)
    Jilma, Bernd
    Roman, Eloy
    Ueda, Yasutaka
    Mappa, Silvia
    Szamosi, Johan
    Savage, Jessica
    Roeth, Alexander
    BLOOD, 2022, 140 : 5326 - 5327
  • [32] Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study
    Takeshima, Takao
    Sakai, Fumihiko
    Hirata, Koichi
    Imai, Noboru
    Matsumori, Yasuhiko
    Yoshida, Ryuji
    Peng, Cheng
    Cheng, Sunfa
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (06): : 927 - 935
  • [33] Daridorexant in Japanese patients with insomnia disorder: A phase 3, randomized, double-blind, placebo-controlled study
    Uchimura, Naohisa
    Taniguchi, Mitsutaka
    Ariyoshi, Yu
    Oka, Yasunori
    Togo, Osamu
    Uchiyama, Makoto
    SLEEP MEDICINE, 2024, 122 : 27 - 34
  • [34] Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
    Motoya, Satoshi
    Watanabe, Kenji
    Ogata, Haruhiko
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Sugiura, Kenkichi
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Watanabe, Mamoru
    Hibi, Toshifumi
    PLOS ONE, 2019, 14 (02):
  • [35] A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease
    Jankovic, J
    Hunter, C
    PARKINSONISM & RELATED DISORDERS, 2002, 8 (04) : 271 - 276
  • [36] Efficacy, safety, and tolerability of the rotigotine transdermal patch in patients with early-stage, idiopathic Parkinson's disease: A multicenter, multinational, randomized, double-blind, placebo-controlled trial
    Watts, RL
    Wendt, J
    Nausieda, PL
    Boroojerdi, B
    Poole, KH
    Sommerville, KW
    MOVEMENT DISORDERS, 2004, 19 : S258 - S258
  • [37] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [38] A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Samidorphan in Adults With Alcohol Dependence
    O'Malley, Stephanie
    Todtenkopf, Mark
    Ehrich, Elliot
    Silverman, Bernard L.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S276 - S276
  • [39] Mechanism of Action and Safety of Seltorexant as a Monotherapy for Patients With Major Depressive Disorder: A Multicenter, Placebo-Controlled, Randomized, Double-Blind, Phase 1 Study
    Savitz, Adam
    Mesens, Sofie
    Kezic, Iva
    Van der Ark, Peter
    Etropolski, Mila
    Drevets, Wayne
    De Boer, Peter
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 308 - 308
  • [40] Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double-blind, placebo-controlled trial
    Xiang, Yingying
    Shen, Lixuan
    Xue, Yingying
    Wang, Ziwei
    Zhou, Ruonan
    Cao, Yue
    Zhu, Ziwei
    Xu, Pingyuan
    Yu, Xizhong
    Fang, Penghua
    Shang, Wenbin
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 5293 - 5303
12345